NEUP (Neuphoria Therapeutics Inc.) Prakiraan volume dodolan

Simbol resmi perusahaan Neuphoria Therapeutics (NEUP)

Neuphoria Therapeutics Inc. (NEUP) is developing antidepressants with stable demand regardless of economic cycles. Diversification through targeted molecules expands its presence in psychiatry, although regulatory complexities and losses create capital risks. The future sales trajectory of Neuphoria Therapeutics Inc. (NEUP) on GURU.Markets analytics helps identify anomalies, while 0.00 represents the latest metric reading.

NEUP - Prakiraan volume dodolan Neuphoria Therapeutics ing rentang 25.12.2024 - 18.11.2026

Rincian metrik komprehensif lan analitis Neuphoria Therapeutics Inc. (NEUP)

Pambiji fundamental:Neuphoria Therapeutics
Sampel barang Neuphoria

For Neuphoria Therapeutics Inc. (NEUP), the target sales dynamics reflect the expected revenue from the commercialization of PTSD treatments. This metric measures capital density by comparing current investments with projected earnings. The calculation is based on the deviation of actual demand from management's implementation plans. For this R&D company, the upward trend confirms the successful navigation of regulatory barriers. Investors should view this trend as an indicator of the transition from clinical trials to market expansion.

Pesaing Neuphoria Therapeutics Inc. (NEUP)

Volume dodolan mangsa ngarep perusahaan BIIB (Biogen)|NBIX (Neurocrine Biosciences, Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Regencell RGC|Prakiraan volume pendapatan perusahaan AXSM (Axsome Therapeutics Inc)|ACADIA Pharmaceuticals - Prakiraan volume dodolan|XENE - Prakiraan volume dodolan|VKTX: Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan SUPN (Supernus)|CPRX (Catalyst Pharmaceuticals Inc) - Prakiraan volume dodolan|DNLI: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan harmonybiosciences.com (HRMY)|Biohaven - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan AMLX (amylyx.com)|Trevi Pharma (TRVI) - Volume dodolan sing dikarepake perusahaan|Praxis Corp - Prakiraan volume dodolan|Anavex Corp (AVXL) - Volume dodolan mangsa ngarep perusahaan|CBLL: Prakiraan volume dodolan|Prothena Biosciences - Pendapatan mangsa ngarep perusahaan|ALEC (alector.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan ANNX (Annexon Biosciences)|Prakiraan pendapatan perusahaan Omeros Corporation (OMER)|Neurogene Corp - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan AC Immune S.A. ACIU|Dodolan mangsa ngarep perusahaan Voyager Therapeutics (VYGR)|Neumora - Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan SCLX|Tevogen Bio Inc. (TVGN) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan ACOG|CGTX (cogrx.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan inhibikase.com (IKT)|Prakiraan pendapatan perusahaan Cassava Sciences Inc (SAVA)|Dodolan mangsa ngarep perusahaan Assertio|Prakiraan volume dodolan COYA (Coya Therapeutics, Inc.)|Prakiraan volume pendapatan perusahaan VTGN (VistaGen Therapeutics Inc)|OVID: Volume dodolan mangsa ngarep perusahaan|ABOS: Prakiraan pendapatan perusahaan|CervoMed (CRVO) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PEPG (PepGen)|Volume dodolan mangsa ngarep perusahaan JUNS (Jupiter Neurosciences, Inc.)|Prakiraan volume dodolan relmada.com (RLMD)|Prakiraan pendapatan perusahaan Annovis Bio Corp ANVS|GRCE: Prakiraan pendapatan perusahaan|AIFF - Prakiraan pendapatan perusahaan|KLTO (anewmeds.com) - Prakiraan pendapatan perusahaan|NRSN (NeuroSense Therapeutics Ltd.) - Volume dodolan mangsa ngarep perusahaan|revivapharma.com - Pendapatan mangsa ngarep perusahaan|MTVA (metaviatx.com) - Prakiraan volume dodolan|NRXS: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan HSDT|PASG - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan Minerva Neurosciences, Inc. NERV|Prakiraan volume dodolan Athira Pharma ATHA|ADXN: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Cortigent (CRGT)|Prakiraan volume dodolan ATXI|BCLI - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Volume dodolan sing dikarepake perusahaan|ELYM - Prakiraan pendapatan perusahaan|Prakiraan dodolan perusahaan intracellulartherapies.com (ITCI)|Longboard (LBPH) - Prakiraan pendapatan perusahaan|Marinus Pharmaceuticals Inc - Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan NKGN|NeuroBo - Pendapatan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan Sage Therapeutics, Inc (SAGE)|Volume dodolan mangsa ngarep perusahaan Synaptogenix SNPX|Trevena, Inc. - Volume dodolan mangsa ngarep perusahaan|VIGL: Prakiraan pendapatan perusahaan|WENA: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Cerevel Therapeutics